Ajinomoto Cambrooke Marks 25 Years of Medical Nutrition Innovation

Celebrating 25 Years of Cambrooke: A Journey of Innovation

Ajinomoto Cambrooke, Inc., a renowned name in the field of medical nutrition, proudly marks its 25th anniversary. This significant milestone is not only a celebration of their past achievements but also an affirmation of their expanded mission: to inspire individuals to live without limits.

The founding of Cambrooke in 2000 was a heartfelt endeavor by Lynn and David Paolella, who launched the initiative from their own kitchen. They aimed to enhance the quality of life for their children diagnosed with phenylketonuria (PKU), a condition that necessitates strict dietary management. By experimenting with recipes, the Paolellas worked tirelessly to ensure nutrition was both effective and enjoyable.

In 2017, Ajinomoto acquired Cambrooke, which strengthened the company's ability to innovate and deliver scientific nutritional solutions globally. As Cambrooke stands today, a quarter-century later, it has evolved into a global entity, dedicated to supporting individuals with PKU and various metabolic disorders.

Reflecting on the company's journey, co-founder Lynn Paolella stated, "When David and I started Cambrooke, we aimed for our children to flourish beyond their condition. Today, that vision has grown beyond our family, impacting countless lives worldwide. Our legacy is built on care, resilience, and the possibility of hope."

Cambrooke President Rick Jentis echoed this sentiment, stating, "For 25 years, we've empowered individuals to embrace freedom and joy despite dietary restrictions. Our mission, 'living without limits,' encapsulates our true essence and encourages our team to innovate freely, shaping what is achievable in medical nutrition."

Cambrooke's innovative trajectory began with the introduction of Homestyle Bread, a product that replaced canned alternatives with delightful freshness. Their collaboration with the University of Wisconsin-Madison led to the pioneering of the first Glycomacropeptide-based (GMP) formula, effectively creating a new category within the field. This advancement gave rise to Glytactin BetterMilk™, specifically designed for individuals managing PKU, and expanded Cambrooke's offerings to address other inborn errors of metabolism (IEM) like Tyrosinemia and Homocystinuria.

The company's innovative spirit did not stop there; addressing the needs of those with intractable epilepsy, Cambrooke launched KetoVie™, a unique liquid ketogenic medical food recognized as the first complete plant-based protein ketogenic formula. Their product line continued to evolve, expanding into allergy and gastrointestinal disorder management with Essential Care Jr.™, the only amino-acid based formula free from corn syrup solids.

Today, Cambrooke collaborates with healthcare professionals and researchers globally to develop and commercialize solutions targeting metabolic disorders, addressing intractable epilepsy, gastrointestinal challenges, and mitigating malnutrition related to chronic diseases.

As they commemorate 25 years of impactful service, Cambrooke invites patients, caregivers, dietitians, and partners to celebrate this milestone and envision a horizon filled with limitless possibilities. By embracing their mission, Cambrooke reaffirms its commitment not just to products but to the potential for transformation and hope that these products offer to individuals and their families.

Ajinomoto Cambrooke, Inc. stands as a beacon in medical nutrition, providing scientifically backed, tailored solutions for those facing unique dietary challenges. To learn more about their journey and products, visit www.cambrooke.com.